nodes	percent_of_prediction	percent_of_DWPC	metapath
Propafenone—ABCB1—kidney cancer	0.183	1	CbGaD
Propafenone—ABCB1—Temsirolimus—kidney cancer	0.0336	0.063	CbGbCtD
Propafenone—KCNH2—Sunitinib—kidney cancer	0.0333	0.0623	CbGbCtD
Propafenone—CYP2D6—Temsirolimus—kidney cancer	0.0317	0.0593	CbGbCtD
Propafenone—CYP3A4—Everolimus—kidney cancer	0.0298	0.0558	CbGbCtD
Propafenone—CYP2C8—Pazopanib—kidney cancer	0.0261	0.0489	CbGbCtD
Propafenone—CYP1A2—Pazopanib—kidney cancer	0.0202	0.0378	CbGbCtD
Propafenone—CYP3A4—Temsirolimus—kidney cancer	0.0201	0.0377	CbGbCtD
Propafenone—CYP2C9—Capecitabine—kidney cancer	0.019	0.0355	CbGbCtD
Propafenone—CYP2C8—Erlotinib—kidney cancer	0.0186	0.0349	CbGbCtD
Propafenone—ABCB1—Pazopanib—kidney cancer	0.0177	0.0331	CbGbCtD
Propafenone—CYP2C8—Paclitaxel—kidney cancer	0.017	0.0319	CbGbCtD
Propafenone—CYP2D6—Pazopanib—kidney cancer	0.0166	0.0312	CbGbCtD
Propafenone—ABCB1—Dactinomycin—kidney cancer	0.0162	0.0302	CbGbCtD
Propafenone—CYP2C8—Sorafenib—kidney cancer	0.0151	0.0283	CbGbCtD
Propafenone—CYP1A2—Erlotinib—kidney cancer	0.0144	0.027	CbGbCtD
Propafenone—ABCB1—Gemcitabine—kidney cancer	0.0128	0.0239	CbGbCtD
Propafenone—ABCB1—Erlotinib—kidney cancer	0.0126	0.0236	CbGbCtD
Propafenone—CYP2C9—Paclitaxel—kidney cancer	0.0119	0.0223	CbGbCtD
Propafenone—CYP2D6—Erlotinib—kidney cancer	0.0119	0.0222	CbGbCtD
Propafenone—CYP1A2—Sorafenib—kidney cancer	0.0117	0.0219	CbGbCtD
Propafenone—ABCB1—Paclitaxel—kidney cancer	0.0115	0.0216	CbGbCtD
Propafenone—CYP3A4—Pazopanib—kidney cancer	0.0106	0.0198	CbGbCtD
Propafenone—CYP2C9—Sorafenib—kidney cancer	0.0106	0.0198	CbGbCtD
Propafenone—ABCB1—Sorafenib—kidney cancer	0.0102	0.0192	CbGbCtD
Propafenone—ABCB1—Vinblastine—kidney cancer	0.0101	0.0189	CbGbCtD
Propafenone—ABCB1—Vincristine—kidney cancer	0.00995	0.0186	CbGbCtD
Propafenone—CYP2D6—Sorafenib—kidney cancer	0.00965	0.0181	CbGbCtD
Propafenone—CYP2D6—Vinblastine—kidney cancer	0.00953	0.0179	CbGbCtD
Propafenone—ABCB1—Sunitinib—kidney cancer	0.0083	0.0155	CbGbCtD
Propafenone—CYP3A4—Erlotinib—kidney cancer	0.00755	0.0141	CbGbCtD
Propafenone—CYP3A4—Paclitaxel—kidney cancer	0.00691	0.0129	CbGbCtD
Propafenone—ABCB1—Doxorubicin—kidney cancer	0.00622	0.0116	CbGbCtD
Propafenone—CYP3A4—Sorafenib—kidney cancer	0.00614	0.0115	CbGbCtD
Propafenone—CYP3A4—Vinblastine—kidney cancer	0.00606	0.0114	CbGbCtD
Propafenone—CYP3A4—Vincristine—kidney cancer	0.00596	0.0112	CbGbCtD
Propafenone—CYP2D6—Doxorubicin—kidney cancer	0.00586	0.011	CbGbCtD
Propafenone—CYP3A4—Sunitinib—kidney cancer	0.00497	0.00931	CbGbCtD
Propafenone—CYP3A4—Doxorubicin—kidney cancer	0.00372	0.00697	CbGbCtD
Propafenone—Carvedilol—HIF1A—kidney cancer	0.000941	0.23	CrCbGaD
Propafenone—CYP1A2—urine—kidney cancer	0.000926	0.148	CbGeAlD
Propafenone—CYP2C9—urine—kidney cancer	0.000879	0.141	CbGeAlD
Propafenone—CYP3A4—urine—kidney cancer	0.00067	0.107	CbGeAlD
Propafenone—CYP2D6—urine—kidney cancer	0.000659	0.106	CbGeAlD
Propafenone—Mirabegron—BCHE—kidney cancer	0.000617	0.151	CrCbGaD
Propafenone—SCN5A—cardiac atrium—kidney cancer	0.000385	0.0617	CbGeAlD
Propafenone—Carvedilol—VEGFA—kidney cancer	0.000379	0.0926	CrCbGaD
Propafenone—Salsalate—PTGS1—kidney cancer	0.00036	0.0879	CrCbGaD
Propafenone—Oxaprozin—PTGS1—kidney cancer	0.00036	0.0879	CrCbGaD
Propafenone—ADRB1—cardiac atrium—kidney cancer	0.00031	0.0497	CbGeAlD
Propafenone—KCNH2—renal system—kidney cancer	0.000265	0.0424	CbGeAlD
Propafenone—CYP2C8—renal system—kidney cancer	0.000242	0.0388	CbGeAlD
Propafenone—Mirabegron—ABCB1—kidney cancer	0.000242	0.0591	CrCbGaD
Propafenone—KCNH2—cardiac atrium—kidney cancer	0.000237	0.0379	CbGeAlD
Propafenone—CYP2C8—kidney—kidney cancer	0.000234	0.0375	CbGeAlD
Propafenone—CYP1A2—renal system—kidney cancer	0.000227	0.0363	CbGeAlD
Propafenone—Salsalate—PTGS2—kidney cancer	0.000206	0.0502	CrCbGaD
Propafenone—Oxaprozin—PTGS2—kidney cancer	0.000206	0.0502	CrCbGaD
Propafenone—Carvedilol—PTGS1—kidney cancer	0.0002	0.0489	CrCbGaD
Propafenone—Carvedilol—CYP1A1—kidney cancer	0.000183	0.0447	CrCbGaD
Propafenone—CYP3A4—renal system—kidney cancer	0.000164	0.0263	CbGeAlD
Propafenone—CYP2D6—renal system—kidney cancer	0.000161	0.0258	CbGeAlD
Propafenone—CYP3A4—kidney—kidney cancer	0.000159	0.0254	CbGeAlD
Propafenone—CYP2D6—kidney—kidney cancer	0.000156	0.025	CbGeAlD
Propafenone—Propranolol—CYP1A1—kidney cancer	0.000139	0.034	CrCbGaD
Propafenone—ABCB1—nephron tubule—kidney cancer	0.000128	0.0204	CbGeAlD
Propafenone—ABCB1—renal system—kidney cancer	0.000116	0.0186	CbGeAlD
Propafenone—ABCB1—kidney—kidney cancer	0.000112	0.018	CbGeAlD
Propafenone—ABCB1—cortex of kidney—kidney cancer	0.000109	0.0175	CbGeAlD
Propafenone—ABCB1—gonad—kidney cancer	0.000104	0.0167	CbGeAlD
Propafenone—Carvedilol—ABCB1—kidney cancer	9.73e-05	0.0238	CrCbGaD
Propafenone—Fentanyl—ABCB1—kidney cancer	8.85e-05	0.0216	CrCbGaD
Propafenone—Propranolol—ABCB1—kidney cancer	7.4e-05	0.0181	CrCbGaD
Propafenone—Mental disorder—Capecitabine—kidney cancer	6.55e-05	0.00027	CcSEcCtD
Propafenone—Asthenia—Dactinomycin—kidney cancer	6.55e-05	0.00027	CcSEcCtD
Propafenone—Confusional state—Paclitaxel—kidney cancer	6.53e-05	0.000269	CcSEcCtD
Propafenone—Blood creatinine increased—Doxorubicin—kidney cancer	6.53e-05	0.000269	CcSEcCtD
Propafenone—Erythema—Capecitabine—kidney cancer	6.51e-05	0.000268	CcSEcCtD
Propafenone—Malnutrition—Capecitabine—kidney cancer	6.51e-05	0.000268	CcSEcCtD
Propafenone—Dehydration—Doxorubicin—kidney cancer	6.48e-05	0.000267	CcSEcCtD
Propafenone—Oedema—Paclitaxel—kidney cancer	6.48e-05	0.000267	CcSEcCtD
Propafenone—Abdominal pain—Vincristine—kidney cancer	6.45e-05	0.000266	CcSEcCtD
Propafenone—Body temperature increased—Vincristine—kidney cancer	6.45e-05	0.000266	CcSEcCtD
Propafenone—Liver function test abnormal—Doxorubicin—kidney cancer	6.44e-05	0.000265	CcSEcCtD
Propafenone—Infection—Paclitaxel—kidney cancer	6.43e-05	0.000265	CcSEcCtD
Propafenone—Flatulence—Capecitabine—kidney cancer	6.42e-05	0.000264	CcSEcCtD
Propafenone—Dry skin—Doxorubicin—kidney cancer	6.39e-05	0.000263	CcSEcCtD
Propafenone—Dysgeusia—Capecitabine—kidney cancer	6.38e-05	0.000263	CcSEcCtD
Propafenone—Dizziness—Sunitinib—kidney cancer	6.38e-05	0.000263	CcSEcCtD
Propafenone—Feeling abnormal—Gemcitabine—kidney cancer	6.37e-05	0.000263	CcSEcCtD
Propafenone—Shock—Paclitaxel—kidney cancer	6.37e-05	0.000262	CcSEcCtD
Propafenone—Vomiting—Sorafenib—kidney cancer	6.37e-05	0.000262	CcSEcCtD
Propafenone—Orthostatic hypotension—Doxorubicin—kidney cancer	6.37e-05	0.000262	CcSEcCtD
Propafenone—Nervous system disorder—Paclitaxel—kidney cancer	6.35e-05	0.000262	CcSEcCtD
Propafenone—Hypokalaemia—Doxorubicin—kidney cancer	6.34e-05	0.000261	CcSEcCtD
Propafenone—Thrombocytopenia—Paclitaxel—kidney cancer	6.34e-05	0.000261	CcSEcCtD
Propafenone—Tachycardia—Paclitaxel—kidney cancer	6.32e-05	0.00026	CcSEcCtD
Propafenone—Rash—Sorafenib—kidney cancer	6.32e-05	0.00026	CcSEcCtD
Propafenone—Dermatitis—Sorafenib—kidney cancer	6.31e-05	0.00026	CcSEcCtD
Propafenone—Breast disorder—Doxorubicin—kidney cancer	6.3e-05	0.000259	CcSEcCtD
Propafenone—Skin disorder—Paclitaxel—kidney cancer	6.29e-05	0.000259	CcSEcCtD
Propafenone—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	6.28e-05	0.000259	CcSEcCtD
Propafenone—Headache—Sorafenib—kidney cancer	6.28e-05	0.000259	CcSEcCtD
Propafenone—Muscle spasms—Capecitabine—kidney cancer	6.26e-05	0.000258	CcSEcCtD
Propafenone—Hyperhidrosis—Paclitaxel—kidney cancer	6.26e-05	0.000258	CcSEcCtD
Propafenone—Diarrhoea—Dactinomycin—kidney cancer	6.24e-05	0.000257	CcSEcCtD
Propafenone—Anorexia—Paclitaxel—kidney cancer	6.17e-05	0.000254	CcSEcCtD
Propafenone—Gastritis—Doxorubicin—kidney cancer	6.17e-05	0.000254	CcSEcCtD
Propafenone—Muscular weakness—Doxorubicin—kidney cancer	6.15e-05	0.000253	CcSEcCtD
Propafenone—Alanine aminotransferase increased—Doxorubicin—kidney cancer	6.15e-05	0.000253	CcSEcCtD
Propafenone—Vision blurred—Capecitabine—kidney cancer	6.14e-05	0.000253	CcSEcCtD
Propafenone—Vomiting—Sunitinib—kidney cancer	6.13e-05	0.000252	CcSEcCtD
Propafenone—Body temperature increased—Gemcitabine—kidney cancer	6.12e-05	0.000252	CcSEcCtD
Propafenone—Tremor—Capecitabine—kidney cancer	6.1e-05	0.000251	CcSEcCtD
Propafenone—Rash—Sunitinib—kidney cancer	6.08e-05	0.00025	CcSEcCtD
Propafenone—Dermatitis—Sunitinib—kidney cancer	6.07e-05	0.00025	CcSEcCtD
Propafenone—Abdominal distension—Doxorubicin—kidney cancer	6.07e-05	0.00025	CcSEcCtD
Propafenone—Hypotension—Paclitaxel—kidney cancer	6.05e-05	0.000249	CcSEcCtD
Propafenone—Ill-defined disorder—Capecitabine—kidney cancer	6.04e-05	0.000249	CcSEcCtD
Propafenone—Headache—Sunitinib—kidney cancer	6.04e-05	0.000249	CcSEcCtD
Propafenone—Dysphagia—Doxorubicin—kidney cancer	6.02e-05	0.000248	CcSEcCtD
Propafenone—Influenza—Doxorubicin—kidney cancer	6.02e-05	0.000248	CcSEcCtD
Propafenone—Anaemia—Capecitabine—kidney cancer	6.02e-05	0.000248	CcSEcCtD
Propafenone—Hypersensitivity—Vincristine—kidney cancer	6.01e-05	0.000247	CcSEcCtD
Propafenone—Eosinophilia—Doxorubicin—kidney cancer	5.97e-05	0.000246	CcSEcCtD
Propafenone—Nausea—Sorafenib—kidney cancer	5.95e-05	0.000245	CcSEcCtD
Propafenone—Pancreatitis—Doxorubicin—kidney cancer	5.91e-05	0.000243	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Paclitaxel—kidney cancer	5.9e-05	0.000243	CcSEcCtD
Propafenone—Malaise—Capecitabine—kidney cancer	5.87e-05	0.000242	CcSEcCtD
Propafenone—Angina pectoris—Doxorubicin—kidney cancer	5.87e-05	0.000242	CcSEcCtD
Propafenone—Insomnia—Paclitaxel—kidney cancer	5.86e-05	0.000241	CcSEcCtD
Propafenone—Vertigo—Capecitabine—kidney cancer	5.85e-05	0.000241	CcSEcCtD
Propafenone—Asthenia—Vincristine—kidney cancer	5.85e-05	0.000241	CcSEcCtD
Propafenone—Syncope—Capecitabine—kidney cancer	5.84e-05	0.000241	CcSEcCtD
Propafenone—Leukopenia—Capecitabine—kidney cancer	5.83e-05	0.00024	CcSEcCtD
Propafenone—Paraesthesia—Paclitaxel—kidney cancer	5.82e-05	0.00024	CcSEcCtD
Propafenone—Vomiting—Dactinomycin—kidney cancer	5.8e-05	0.000239	CcSEcCtD
Propafenone—Dyspnoea—Paclitaxel—kidney cancer	5.77e-05	0.000238	CcSEcCtD
Propafenone—Somnolence—Paclitaxel—kidney cancer	5.76e-05	0.000237	CcSEcCtD
Propafenone—Palpitations—Capecitabine—kidney cancer	5.76e-05	0.000237	CcSEcCtD
Propafenone—Rash—Dactinomycin—kidney cancer	5.75e-05	0.000237	CcSEcCtD
Propafenone—Nausea—Sunitinib—kidney cancer	5.73e-05	0.000236	CcSEcCtD
Propafenone—Loss of consciousness—Capecitabine—kidney cancer	5.72e-05	0.000236	CcSEcCtD
Propafenone—Dyspepsia—Paclitaxel—kidney cancer	5.7e-05	0.000235	CcSEcCtD
Propafenone—Cough—Capecitabine—kidney cancer	5.68e-05	0.000234	CcSEcCtD
Propafenone—Dysuria—Doxorubicin—kidney cancer	5.63e-05	0.000232	CcSEcCtD
Propafenone—Decreased appetite—Paclitaxel—kidney cancer	5.63e-05	0.000232	CcSEcCtD
Propafenone—Hypertension—Capecitabine—kidney cancer	5.62e-05	0.000232	CcSEcCtD
Propafenone—Upper respiratory tract infection—Doxorubicin—kidney cancer	5.6e-05	0.000231	CcSEcCtD
Propafenone—Gastrointestinal disorder—Paclitaxel—kidney cancer	5.59e-05	0.00023	CcSEcCtD
Propafenone—Fatigue—Paclitaxel—kidney cancer	5.58e-05	0.00023	CcSEcCtD
Propafenone—Diarrhoea—Vincristine—kidney cancer	5.58e-05	0.00023	CcSEcCtD
Propafenone—Pollakiuria—Doxorubicin—kidney cancer	5.57e-05	0.000229	CcSEcCtD
Propafenone—Asthenia—Gemcitabine—kidney cancer	5.55e-05	0.000229	CcSEcCtD
Propafenone—Chest pain—Capecitabine—kidney cancer	5.54e-05	0.000228	CcSEcCtD
Propafenone—Myalgia—Capecitabine—kidney cancer	5.54e-05	0.000228	CcSEcCtD
Propafenone—Pain—Paclitaxel—kidney cancer	5.54e-05	0.000228	CcSEcCtD
Propafenone—Constipation—Paclitaxel—kidney cancer	5.54e-05	0.000228	CcSEcCtD
Propafenone—Anxiety—Capecitabine—kidney cancer	5.53e-05	0.000228	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	5.51e-05	0.000227	CcSEcCtD
Propafenone—Weight increased—Doxorubicin—kidney cancer	5.48e-05	0.000226	CcSEcCtD
Propafenone—Discomfort—Capecitabine—kidney cancer	5.48e-05	0.000226	CcSEcCtD
Propafenone—Pruritus—Gemcitabine—kidney cancer	5.47e-05	0.000225	CcSEcCtD
Propafenone—Weight decreased—Doxorubicin—kidney cancer	5.45e-05	0.000225	CcSEcCtD
Propafenone—Hyperglycaemia—Doxorubicin—kidney cancer	5.43e-05	0.000224	CcSEcCtD
Propafenone—Dry mouth—Capecitabine—kidney cancer	5.42e-05	0.000223	CcSEcCtD
Propafenone—Nausea—Dactinomycin—kidney cancer	5.42e-05	0.000223	CcSEcCtD
Propafenone—Dizziness—Vincristine—kidney cancer	5.39e-05	0.000222	CcSEcCtD
Propafenone—Infestation—Doxorubicin—kidney cancer	5.37e-05	0.000221	CcSEcCtD
Propafenone—Infestation NOS—Doxorubicin—kidney cancer	5.37e-05	0.000221	CcSEcCtD
Propafenone—Drowsiness—Doxorubicin—kidney cancer	5.37e-05	0.000221	CcSEcCtD
Propafenone—Confusional state—Capecitabine—kidney cancer	5.36e-05	0.000221	CcSEcCtD
Propafenone—Feeling abnormal—Paclitaxel—kidney cancer	5.34e-05	0.00022	CcSEcCtD
Propafenone—Oedema—Capecitabine—kidney cancer	5.31e-05	0.000219	CcSEcCtD
Propafenone—Gastrointestinal pain—Paclitaxel—kidney cancer	5.3e-05	0.000218	CcSEcCtD
Propafenone—Diarrhoea—Gemcitabine—kidney cancer	5.29e-05	0.000218	CcSEcCtD
Propafenone—Renal failure—Doxorubicin—kidney cancer	5.28e-05	0.000217	CcSEcCtD
Propafenone—Infection—Capecitabine—kidney cancer	5.28e-05	0.000217	CcSEcCtD
Propafenone—Neuropathy peripheral—Doxorubicin—kidney cancer	5.27e-05	0.000217	CcSEcCtD
Propafenone—Jaundice—Doxorubicin—kidney cancer	5.24e-05	0.000216	CcSEcCtD
Propafenone—Stomatitis—Doxorubicin—kidney cancer	5.24e-05	0.000216	CcSEcCtD
Propafenone—Shock—Capecitabine—kidney cancer	5.23e-05	0.000215	CcSEcCtD
Propafenone—Nervous system disorder—Capecitabine—kidney cancer	5.21e-05	0.000215	CcSEcCtD
Propafenone—Thrombocytopenia—Capecitabine—kidney cancer	5.2e-05	0.000214	CcSEcCtD
Propafenone—Tachycardia—Capecitabine—kidney cancer	5.19e-05	0.000214	CcSEcCtD
Propafenone—Vomiting—Vincristine—kidney cancer	5.18e-05	0.000214	CcSEcCtD
Propafenone—Skin disorder—Capecitabine—kidney cancer	5.16e-05	0.000213	CcSEcCtD
Propafenone—Urticaria—Paclitaxel—kidney cancer	5.15e-05	0.000212	CcSEcCtD
Propafenone—Rash—Vincristine—kidney cancer	5.14e-05	0.000212	CcSEcCtD
Propafenone—Hyperhidrosis—Capecitabine—kidney cancer	5.14e-05	0.000212	CcSEcCtD
Propafenone—Dermatitis—Vincristine—kidney cancer	5.14e-05	0.000212	CcSEcCtD
Propafenone—Haematuria—Doxorubicin—kidney cancer	5.12e-05	0.000211	CcSEcCtD
Propafenone—Abdominal pain—Paclitaxel—kidney cancer	5.12e-05	0.000211	CcSEcCtD
Propafenone—Body temperature increased—Paclitaxel—kidney cancer	5.12e-05	0.000211	CcSEcCtD
Propafenone—Headache—Vincristine—kidney cancer	5.11e-05	0.00021	CcSEcCtD
Propafenone—Hepatobiliary disease—Doxorubicin—kidney cancer	5.08e-05	0.000209	CcSEcCtD
Propafenone—Epistaxis—Doxorubicin—kidney cancer	5.07e-05	0.000209	CcSEcCtD
Propafenone—Anorexia—Capecitabine—kidney cancer	5.07e-05	0.000209	CcSEcCtD
Propafenone—Agranulocytosis—Doxorubicin—kidney cancer	5.01e-05	0.000206	CcSEcCtD
Propafenone—Hypotension—Capecitabine—kidney cancer	4.97e-05	0.000205	CcSEcCtD
Propafenone—Vomiting—Gemcitabine—kidney cancer	4.92e-05	0.000203	CcSEcCtD
Propafenone—Bradycardia—Doxorubicin—kidney cancer	4.91e-05	0.000202	CcSEcCtD
Propafenone—Rash—Gemcitabine—kidney cancer	4.88e-05	0.000201	CcSEcCtD
Propafenone—Dermatitis—Gemcitabine—kidney cancer	4.87e-05	0.000201	CcSEcCtD
Propafenone—Haemoglobin—Doxorubicin—kidney cancer	4.85e-05	0.0002	CcSEcCtD
Propafenone—Headache—Gemcitabine—kidney cancer	4.85e-05	0.0002	CcSEcCtD
Propafenone—Nausea—Vincristine—kidney cancer	4.84e-05	0.0002	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Capecitabine—kidney cancer	4.84e-05	0.000199	CcSEcCtD
Propafenone—Rhinitis—Doxorubicin—kidney cancer	4.83e-05	0.000199	CcSEcCtD
Propafenone—Haemorrhage—Doxorubicin—kidney cancer	4.82e-05	0.000199	CcSEcCtD
Propafenone—Hepatitis—Doxorubicin—kidney cancer	4.82e-05	0.000199	CcSEcCtD
Propafenone—Insomnia—Capecitabine—kidney cancer	4.81e-05	0.000198	CcSEcCtD
Propafenone—Hypoaesthesia—Doxorubicin—kidney cancer	4.8e-05	0.000198	CcSEcCtD
Propafenone—Paraesthesia—Capecitabine—kidney cancer	4.77e-05	0.000197	CcSEcCtD
Propafenone—Hypersensitivity—Paclitaxel—kidney cancer	4.77e-05	0.000197	CcSEcCtD
Propafenone—Urinary tract disorder—Doxorubicin—kidney cancer	4.76e-05	0.000196	CcSEcCtD
Propafenone—Connective tissue disorder—Doxorubicin—kidney cancer	4.74e-05	0.000195	CcSEcCtD
Propafenone—Dyspnoea—Capecitabine—kidney cancer	4.74e-05	0.000195	CcSEcCtD
Propafenone—Urethral disorder—Doxorubicin—kidney cancer	4.73e-05	0.000195	CcSEcCtD
Propafenone—Dyspepsia—Capecitabine—kidney cancer	4.68e-05	0.000193	CcSEcCtD
Propafenone—Visual impairment—Doxorubicin—kidney cancer	4.65e-05	0.000191	CcSEcCtD
Propafenone—Asthenia—Paclitaxel—kidney cancer	4.65e-05	0.000191	CcSEcCtD
Propafenone—Decreased appetite—Capecitabine—kidney cancer	4.62e-05	0.00019	CcSEcCtD
Propafenone—Nausea—Gemcitabine—kidney cancer	4.59e-05	0.000189	CcSEcCtD
Propafenone—Gastrointestinal disorder—Capecitabine—kidney cancer	4.59e-05	0.000189	CcSEcCtD
Propafenone—Fatigue—Capecitabine—kidney cancer	4.58e-05	0.000189	CcSEcCtD
Propafenone—Pruritus—Paclitaxel—kidney cancer	4.58e-05	0.000189	CcSEcCtD
Propafenone—Pain—Capecitabine—kidney cancer	4.55e-05	0.000187	CcSEcCtD
Propafenone—Constipation—Capecitabine—kidney cancer	4.55e-05	0.000187	CcSEcCtD
Propafenone—Eye disorder—Doxorubicin—kidney cancer	4.51e-05	0.000186	CcSEcCtD
Propafenone—Tinnitus—Doxorubicin—kidney cancer	4.5e-05	0.000185	CcSEcCtD
Propafenone—Cardiac disorder—Doxorubicin—kidney cancer	4.48e-05	0.000184	CcSEcCtD
Propafenone—Flushing—Doxorubicin—kidney cancer	4.48e-05	0.000184	CcSEcCtD
Propafenone—Diarrhoea—Paclitaxel—kidney cancer	4.43e-05	0.000183	CcSEcCtD
Propafenone—Feeling abnormal—Capecitabine—kidney cancer	4.38e-05	0.00018	CcSEcCtD
Propafenone—Angiopathy—Doxorubicin—kidney cancer	4.38e-05	0.00018	CcSEcCtD
Propafenone—Immune system disorder—Doxorubicin—kidney cancer	4.36e-05	0.000179	CcSEcCtD
Propafenone—Gastrointestinal pain—Capecitabine—kidney cancer	4.35e-05	0.000179	CcSEcCtD
Propafenone—Mediastinal disorder—Doxorubicin—kidney cancer	4.35e-05	0.000179	CcSEcCtD
Propafenone—Arrhythmia—Doxorubicin—kidney cancer	4.31e-05	0.000177	CcSEcCtD
Propafenone—Dizziness—Paclitaxel—kidney cancer	4.28e-05	0.000176	CcSEcCtD
Propafenone—Alopecia—Doxorubicin—kidney cancer	4.26e-05	0.000176	CcSEcCtD
Propafenone—Mental disorder—Doxorubicin—kidney cancer	4.22e-05	0.000174	CcSEcCtD
Propafenone—Urticaria—Capecitabine—kidney cancer	4.22e-05	0.000174	CcSEcCtD
Propafenone—Body temperature increased—Capecitabine—kidney cancer	4.2e-05	0.000173	CcSEcCtD
Propafenone—Abdominal pain—Capecitabine—kidney cancer	4.2e-05	0.000173	CcSEcCtD
Propafenone—Malnutrition—Doxorubicin—kidney cancer	4.2e-05	0.000173	CcSEcCtD
Propafenone—Erythema—Doxorubicin—kidney cancer	4.2e-05	0.000173	CcSEcCtD
Propafenone—Flatulence—Doxorubicin—kidney cancer	4.14e-05	0.00017	CcSEcCtD
Propafenone—Tension—Doxorubicin—kidney cancer	4.12e-05	0.00017	CcSEcCtD
Propafenone—Vomiting—Paclitaxel—kidney cancer	4.12e-05	0.00017	CcSEcCtD
Propafenone—Dysgeusia—Doxorubicin—kidney cancer	4.11e-05	0.000169	CcSEcCtD
Propafenone—Rash—Paclitaxel—kidney cancer	4.08e-05	0.000168	CcSEcCtD
Propafenone—Dermatitis—Paclitaxel—kidney cancer	4.08e-05	0.000168	CcSEcCtD
Propafenone—Nervousness—Doxorubicin—kidney cancer	4.08e-05	0.000168	CcSEcCtD
Propafenone—Headache—Paclitaxel—kidney cancer	4.06e-05	0.000167	CcSEcCtD
Propafenone—Muscle spasms—Doxorubicin—kidney cancer	4.04e-05	0.000166	CcSEcCtD
Propafenone—Vision blurred—Doxorubicin—kidney cancer	3.96e-05	0.000163	CcSEcCtD
Propafenone—Hypersensitivity—Capecitabine—kidney cancer	3.92e-05	0.000161	CcSEcCtD
Propafenone—Ill-defined disorder—Doxorubicin—kidney cancer	3.89e-05	0.00016	CcSEcCtD
Propafenone—Anaemia—Doxorubicin—kidney cancer	3.88e-05	0.00016	CcSEcCtD
Propafenone—Nausea—Paclitaxel—kidney cancer	3.85e-05	0.000158	CcSEcCtD
Propafenone—Asthenia—Capecitabine—kidney cancer	3.81e-05	0.000157	CcSEcCtD
Propafenone—Malaise—Doxorubicin—kidney cancer	3.79e-05	0.000156	CcSEcCtD
Propafenone—Vertigo—Doxorubicin—kidney cancer	3.77e-05	0.000155	CcSEcCtD
Propafenone—Syncope—Doxorubicin—kidney cancer	3.76e-05	0.000155	CcSEcCtD
Propafenone—Pruritus—Capecitabine—kidney cancer	3.76e-05	0.000155	CcSEcCtD
Propafenone—Leukopenia—Doxorubicin—kidney cancer	3.76e-05	0.000155	CcSEcCtD
Propafenone—Palpitations—Doxorubicin—kidney cancer	3.71e-05	0.000153	CcSEcCtD
Propafenone—Loss of consciousness—Doxorubicin—kidney cancer	3.69e-05	0.000152	CcSEcCtD
Propafenone—Cough—Doxorubicin—kidney cancer	3.66e-05	0.000151	CcSEcCtD
Propafenone—Convulsion—Doxorubicin—kidney cancer	3.64e-05	0.00015	CcSEcCtD
Propafenone—Diarrhoea—Capecitabine—kidney cancer	3.64e-05	0.00015	CcSEcCtD
Propafenone—Hypertension—Doxorubicin—kidney cancer	3.62e-05	0.000149	CcSEcCtD
Propafenone—Myalgia—Doxorubicin—kidney cancer	3.57e-05	0.000147	CcSEcCtD
Propafenone—Chest pain—Doxorubicin—kidney cancer	3.57e-05	0.000147	CcSEcCtD
Propafenone—Anxiety—Doxorubicin—kidney cancer	3.56e-05	0.000147	CcSEcCtD
Propafenone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	3.55e-05	0.000146	CcSEcCtD
Propafenone—Discomfort—Doxorubicin—kidney cancer	3.53e-05	0.000145	CcSEcCtD
Propafenone—Dizziness—Capecitabine—kidney cancer	3.51e-05	0.000145	CcSEcCtD
Propafenone—Dry mouth—Doxorubicin—kidney cancer	3.5e-05	0.000144	CcSEcCtD
Propafenone—Confusional state—Doxorubicin—kidney cancer	3.45e-05	0.000142	CcSEcCtD
Propafenone—Oedema—Doxorubicin—kidney cancer	3.43e-05	0.000141	CcSEcCtD
Propafenone—Infection—Doxorubicin—kidney cancer	3.4e-05	0.00014	CcSEcCtD
Propafenone—Vomiting—Capecitabine—kidney cancer	3.38e-05	0.000139	CcSEcCtD
Propafenone—Shock—Doxorubicin—kidney cancer	3.37e-05	0.000139	CcSEcCtD
Propafenone—Nervous system disorder—Doxorubicin—kidney cancer	3.36e-05	0.000138	CcSEcCtD
Propafenone—Thrombocytopenia—Doxorubicin—kidney cancer	3.35e-05	0.000138	CcSEcCtD
Propafenone—Rash—Capecitabine—kidney cancer	3.35e-05	0.000138	CcSEcCtD
Propafenone—Dermatitis—Capecitabine—kidney cancer	3.35e-05	0.000138	CcSEcCtD
Propafenone—Tachycardia—Doxorubicin—kidney cancer	3.34e-05	0.000138	CcSEcCtD
Propafenone—Headache—Capecitabine—kidney cancer	3.33e-05	0.000137	CcSEcCtD
Propafenone—Skin disorder—Doxorubicin—kidney cancer	3.33e-05	0.000137	CcSEcCtD
Propafenone—Hyperhidrosis—Doxorubicin—kidney cancer	3.31e-05	0.000136	CcSEcCtD
Propafenone—Anorexia—Doxorubicin—kidney cancer	3.27e-05	0.000135	CcSEcCtD
Propafenone—Hypotension—Doxorubicin—kidney cancer	3.2e-05	0.000132	CcSEcCtD
Propafenone—Nausea—Capecitabine—kidney cancer	3.16e-05	0.00013	CcSEcCtD
Propafenone—Musculoskeletal discomfort—Doxorubicin—kidney cancer	3.12e-05	0.000129	CcSEcCtD
Propafenone—Insomnia—Doxorubicin—kidney cancer	3.1e-05	0.000128	CcSEcCtD
Propafenone—Paraesthesia—Doxorubicin—kidney cancer	3.08e-05	0.000127	CcSEcCtD
Propafenone—Dyspnoea—Doxorubicin—kidney cancer	3.05e-05	0.000126	CcSEcCtD
Propafenone—Somnolence—Doxorubicin—kidney cancer	3.05e-05	0.000125	CcSEcCtD
Propafenone—Dyspepsia—Doxorubicin—kidney cancer	3.02e-05	0.000124	CcSEcCtD
Propafenone—Decreased appetite—Doxorubicin—kidney cancer	2.98e-05	0.000123	CcSEcCtD
Propafenone—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.96e-05	0.000122	CcSEcCtD
Propafenone—Fatigue—Doxorubicin—kidney cancer	2.95e-05	0.000122	CcSEcCtD
Propafenone—Pain—Doxorubicin—kidney cancer	2.93e-05	0.000121	CcSEcCtD
Propafenone—Constipation—Doxorubicin—kidney cancer	2.93e-05	0.000121	CcSEcCtD
Propafenone—Feeling abnormal—Doxorubicin—kidney cancer	2.82e-05	0.000116	CcSEcCtD
Propafenone—Gastrointestinal pain—Doxorubicin—kidney cancer	2.8e-05	0.000115	CcSEcCtD
Propafenone—Urticaria—Doxorubicin—kidney cancer	2.72e-05	0.000112	CcSEcCtD
Propafenone—Abdominal pain—Doxorubicin—kidney cancer	2.71e-05	0.000112	CcSEcCtD
Propafenone—Body temperature increased—Doxorubicin—kidney cancer	2.71e-05	0.000112	CcSEcCtD
Propafenone—Hypersensitivity—Doxorubicin—kidney cancer	2.52e-05	0.000104	CcSEcCtD
Propafenone—Asthenia—Doxorubicin—kidney cancer	2.46e-05	0.000101	CcSEcCtD
Propafenone—Pruritus—Doxorubicin—kidney cancer	2.42e-05	9.98e-05	CcSEcCtD
Propafenone—Diarrhoea—Doxorubicin—kidney cancer	2.34e-05	9.66e-05	CcSEcCtD
Propafenone—Dizziness—Doxorubicin—kidney cancer	2.27e-05	9.33e-05	CcSEcCtD
Propafenone—Vomiting—Doxorubicin—kidney cancer	2.18e-05	8.97e-05	CcSEcCtD
Propafenone—Rash—Doxorubicin—kidney cancer	2.16e-05	8.9e-05	CcSEcCtD
Propafenone—Dermatitis—Doxorubicin—kidney cancer	2.16e-05	8.89e-05	CcSEcCtD
Propafenone—Headache—Doxorubicin—kidney cancer	2.15e-05	8.84e-05	CcSEcCtD
Propafenone—Nausea—Doxorubicin—kidney cancer	2.04e-05	8.38e-05	CcSEcCtD
Propafenone—CYP2C8—Metabolism—SLC5A3—kidney cancer	1.34e-05	0.000454	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—FH—kidney cancer	1.34e-05	0.000453	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—APRT—kidney cancer	1.34e-05	0.000453	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.32e-05	0.000446	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—LDHB—kidney cancer	1.32e-05	0.000445	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA2—kidney cancer	1.31e-05	0.000444	CbGpPWpGaD
Propafenone—SCN5A—Developmental Biology—KRAS—kidney cancer	1.31e-05	0.000444	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	1.31e-05	0.000444	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.31e-05	0.000443	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	1.29e-05	0.000435	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALAD—kidney cancer	1.28e-05	0.000433	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.27e-05	0.00043	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GPC3—kidney cancer	1.27e-05	0.00043	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ITPR2—kidney cancer	1.27e-05	0.000428	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GPC3—kidney cancer	1.26e-05	0.000426	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	1.25e-05	0.000423	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ST3GAL2—kidney cancer	1.25e-05	0.000422	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	1.25e-05	0.000422	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	1.24e-05	0.000419	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA2—kidney cancer	1.24e-05	0.000418	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GLIPR1—kidney cancer	1.23e-05	0.000417	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PPAT—kidney cancer	1.23e-05	0.000417	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA2—kidney cancer	1.23e-05	0.000415	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ALDH1A1—kidney cancer	1.22e-05	0.000413	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	1.22e-05	0.000412	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	1.21e-05	0.000408	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALAD—kidney cancer	1.21e-05	0.000408	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	1.21e-05	0.000407	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALAD—kidney cancer	1.2e-05	0.000404	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ST3GAL2—kidney cancer	1.18e-05	0.000398	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC5A3—kidney cancer	1.17e-05	0.000396	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PGK1—kidney cancer	1.17e-05	0.000396	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PDHB—kidney cancer	1.17e-05	0.000395	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ST3GAL2—kidney cancer	1.17e-05	0.000394	CbGpPWpGaD
Propafenone—CYP3A4—Biological oxidations—POMC—kidney cancer	1.16e-05	0.000393	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ALDH1A1—kidney cancer	1.15e-05	0.000389	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—LDHB—kidney cancer	1.15e-05	0.000388	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CTNNA1—kidney cancer	1.15e-05	0.000388	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—APRT—kidney cancer	1.15e-05	0.000387	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—FH—kidney cancer	1.15e-05	0.000387	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CA9—kidney cancer	1.14e-05	0.000386	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—EIF4EBP1—kidney cancer	1.14e-05	0.000386	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HSPB1—kidney cancer	1.14e-05	0.000386	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ALDH1A1—kidney cancer	1.14e-05	0.000386	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	1.12e-05	0.000379	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	1.12e-05	0.000377	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC5A3—kidney cancer	1.1e-05	0.000373	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PGK1—kidney cancer	1.1e-05	0.000373	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CCBL1—kidney cancer	1.1e-05	0.000371	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC5A3—kidney cancer	1.09e-05	0.00037	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PGK1—kidney cancer	1.09e-05	0.00037	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	1.09e-05	0.000369	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—LDHB—kidney cancer	1.08e-05	0.000366	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GPC3—kidney cancer	1.08e-05	0.000364	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—LDHB—kidney cancer	1.07e-05	0.000363	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PSMD7—kidney cancer	1.06e-05	0.000358	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TSC1—kidney cancer	1.06e-05	0.000358	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ANXA1—kidney cancer	1.06e-05	0.000358	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA2—kidney cancer	1.05e-05	0.000354	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	1.03e-05	0.000349	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—FLT1—kidney cancer	1.03e-05	0.000347	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALAD—kidney cancer	1.02e-05	0.000345	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	1.01e-05	0.000339	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ST3GAL2—kidney cancer	9.98e-06	0.000337	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CA9—kidney cancer	9.96e-06	0.000336	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	9.83e-06	0.000332	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ALDH1A1—kidney cancer	9.76e-06	0.000329	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CRABP1—kidney cancer	9.72e-06	0.000328	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—POMC—kidney cancer	9.69e-06	0.000327	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JUNB—kidney cancer	9.53e-06	0.000322	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PAK1—kidney cancer	9.53e-06	0.000322	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PPAT—kidney cancer	9.53e-06	0.000322	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GLIPR1—kidney cancer	9.53e-06	0.000322	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CA9—kidney cancer	9.39e-06	0.000317	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PGK1—kidney cancer	9.35e-06	0.000316	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC5A3—kidney cancer	9.35e-06	0.000316	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CA9—kidney cancer	9.31e-06	0.000314	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	9.29e-06	0.000314	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—LDHB—kidney cancer	9.17e-06	0.00031	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	9.1e-06	0.000307	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ITPR2—kidney cancer	9.04e-06	0.000305	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—APRT—kidney cancer	8.86e-06	0.000299	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—FH—kidney cancer	8.86e-06	0.000299	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—POMC—kidney cancer	8.8e-06	0.000297	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	8.53e-06	0.000288	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CRABP1—kidney cancer	8.47e-06	0.000286	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	8.33e-06	0.000281	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GPC3—kidney cancer	8.33e-06	0.000281	CbGpPWpGaD
Propafenone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	8.25e-06	0.000279	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTT1—kidney cancer	8.24e-06	0.000278	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ACHE—kidney cancer	8.24e-06	0.000278	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA2—kidney cancer	8.1e-06	0.000274	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CRABP1—kidney cancer	7.98e-06	0.00027	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CA9—kidney cancer	7.95e-06	0.000269	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CRABP1—kidney cancer	7.91e-06	0.000267	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALAD—kidney cancer	7.89e-06	0.000267	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ITPR2—kidney cancer	7.88e-06	0.000266	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SCARB1—kidney cancer	7.8e-06	0.000264	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF2—kidney cancer	7.79e-06	0.000263	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.77e-06	0.000263	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN2B—kidney cancer	7.76e-06	0.000262	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS1—kidney cancer	7.72e-06	0.000261	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ST3GAL2—kidney cancer	7.7e-06	0.00026	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PSMD7—kidney cancer	7.58e-06	0.000256	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IGF1R—kidney cancer	7.53e-06	0.000254	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ALDH1A1—kidney cancer	7.53e-06	0.000254	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ITPR2—kidney cancer	7.42e-06	0.000251	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ITPR2—kidney cancer	7.36e-06	0.000248	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—RAF1—kidney cancer	7.26e-06	0.000245	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC5A3—kidney cancer	7.22e-06	0.000244	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PGK1—kidney cancer	7.22e-06	0.000244	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTT1—kidney cancer	7.18e-06	0.000243	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—ACHE—kidney cancer	7.18e-06	0.000243	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—BCHE—kidney cancer	7.18e-06	0.000243	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—IL2—kidney cancer	7.17e-06	0.000242	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SLC5A5—kidney cancer	7.09e-06	0.00024	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—LDHB—kidney cancer	7.08e-06	0.000239	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—SLC2A1—kidney cancer	6.85e-06	0.000231	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SCARB1—kidney cancer	6.8e-06	0.00023	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.78e-06	0.000229	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ACHE—kidney cancer	6.77e-06	0.000229	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTT1—kidney cancer	6.77e-06	0.000229	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CRABP1—kidney cancer	6.76e-06	0.000228	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS1—kidney cancer	6.73e-06	0.000227	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ACHE—kidney cancer	6.71e-06	0.000227	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTT1—kidney cancer	6.71e-06	0.000227	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	6.65e-06	0.000224	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PSMD7—kidney cancer	6.6e-06	0.000223	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—IL2—kidney cancer	6.51e-06	0.00022	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SCARB1—kidney cancer	6.41e-06	0.000216	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SCARB1—kidney cancer	6.35e-06	0.000214	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS1—kidney cancer	6.34e-06	0.000214	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ITPR2—kidney cancer	6.29e-06	0.000212	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS1—kidney cancer	6.29e-06	0.000212	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—BCHE—kidney cancer	6.26e-06	0.000211	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PSMD7—kidney cancer	6.22e-06	0.00021	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—HIF1A—kidney cancer	6.2e-06	0.000209	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TSC2—kidney cancer	6.19e-06	0.000209	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC5A5—kidney cancer	6.18e-06	0.000209	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PSMD7—kidney cancer	6.17e-06	0.000208	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CA9—kidney cancer	6.14e-06	0.000207	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—SLC2A1—kidney cancer	5.97e-06	0.000202	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KDR—kidney cancer	5.93e-06	0.0002	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—BCHE—kidney cancer	5.9e-06	0.000199	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—BCHE—kidney cancer	5.84e-06	0.000197	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC5A5—kidney cancer	5.82e-06	0.000197	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	5.8e-06	0.000196	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.8e-06	0.000196	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC5A5—kidney cancer	5.77e-06	0.000195	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ACHE—kidney cancer	5.73e-06	0.000194	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTT1—kidney cancer	5.73e-06	0.000194	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTP1—kidney cancer	5.71e-06	0.000193	CbGpPWpGaD
Propafenone—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	5.69e-06	0.000192	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—SLC2A1—kidney cancer	5.62e-06	0.00019	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—SLC2A1—kidney cancer	5.58e-06	0.000188	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—APC—kidney cancer	5.46e-06	0.000185	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KIT—kidney cancer	5.46e-06	0.000185	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SCARB1—kidney cancer	5.43e-06	0.000183	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.41e-06	0.000183	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—ABCB1—kidney cancer	5.41e-06	0.000183	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS1—kidney cancer	5.37e-06	0.000181	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PSMD7—kidney cancer	5.27e-06	0.000178	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—GSTM1—kidney cancer	5.25e-06	0.000177	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK3—kidney cancer	5.23e-06	0.000177	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CRABP1—kidney cancer	5.22e-06	0.000176	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—POMC—kidney cancer	5.2e-06	0.000176	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—BRAF—kidney cancer	5.14e-06	0.000173	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—BCHE—kidney cancer	4.99e-06	0.000169	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—MAPK1—kidney cancer	4.98e-06	0.000168	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTP1—kidney cancer	4.98e-06	0.000168	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—CYP1A1—kidney cancer	4.98e-06	0.000168	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC5A5—kidney cancer	4.93e-06	0.000167	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ITPR2—kidney cancer	4.85e-06	0.000164	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—SLC2A1—kidney cancer	4.76e-06	0.000161	CbGpPWpGaD
Propafenone—ADRB1—GPCR downstream signaling—PIK3CA—kidney cancer	4.76e-06	0.000161	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.72e-06	0.000159	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—KRAS—kidney cancer	4.7e-06	0.000159	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTP1—kidney cancer	4.69e-06	0.000158	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTP1—kidney cancer	4.65e-06	0.000157	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.62e-06	0.000156	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—GSTM1—kidney cancer	4.57e-06	0.000154	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—ABCB1—kidney cancer	4.44e-06	0.00015	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ACHE—kidney cancer	4.42e-06	0.000149	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTT1—kidney cancer	4.42e-06	0.000149	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—ABCB1—kidney cancer	4.4e-06	0.000149	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—CYP1A1—kidney cancer	4.34e-06	0.000146	CbGpPWpGaD
Propafenone—ADRB1—Signaling by GPCR—PIK3CA—kidney cancer	4.32e-06	0.000146	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—GSTM1—kidney cancer	4.31e-06	0.000146	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RAF1—kidney cancer	4.29e-06	0.000145	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—GSTM1—kidney cancer	4.27e-06	0.000144	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—RELA—kidney cancer	4.27e-06	0.000144	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—ERBB2—kidney cancer	4.24e-06	0.000143	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SCARB1—kidney cancer	4.19e-06	0.000141	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MTOR—kidney cancer	4.19e-06	0.000141	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS1—kidney cancer	4.15e-06	0.00014	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	4.09e-06	0.000138	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—CYP1A1—kidney cancer	4.09e-06	0.000138	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PSMD7—kidney cancer	4.07e-06	0.000137	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—CYP1A1—kidney cancer	4.05e-06	0.000137	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.03e-06	0.000136	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTP1—kidney cancer	3.97e-06	0.000134	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CDKN1B—kidney cancer	3.93e-06	0.000133	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—BCHE—kidney cancer	3.85e-06	0.00013	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—IL2—kidney cancer	3.84e-06	0.00013	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC5A5—kidney cancer	3.81e-06	0.000129	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—ABCB1—kidney cancer	3.76e-06	0.000127	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CCND1—kidney cancer	3.75e-06	0.000127	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—JUN—kidney cancer	3.74e-06	0.000126	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—CTNNB1—kidney cancer	3.71e-06	0.000125	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—POMC—kidney cancer	3.71e-06	0.000125	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—SLC2A1—kidney cancer	3.68e-06	0.000124	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—GSTM1—kidney cancer	3.65e-06	0.000123	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PTEN—kidney cancer	3.62e-06	0.000122	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—CYP1A1—kidney cancer	3.46e-06	0.000117	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.33e-06	0.000112	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—VEGFA—kidney cancer	3.27e-06	0.00011	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—POMC—kidney cancer	3.23e-06	0.000109	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK3—kidney cancer	3.09e-06	0.000104	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTP1—kidney cancer	3.07e-06	0.000104	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—POMC—kidney cancer	3.05e-06	0.000103	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—POMC—kidney cancer	3.02e-06	0.000102	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MYC—kidney cancer	3.01e-06	0.000102	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTGS2—kidney cancer	2.96e-06	0.0001	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—MAPK1—kidney cancer	2.94e-06	9.93e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—ABCB1—kidney cancer	2.9e-06	9.8e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.84e-06	9.6e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—GSTM1—kidney cancer	2.82e-06	9.52e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—KRAS—kidney cancer	2.78e-06	9.38e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.67e-06	9.02e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PTEN—kidney cancer	2.58e-06	8.72e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—POMC—kidney cancer	2.58e-06	8.72e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTGS2—kidney cancer	2.58e-06	8.71e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—PIK3CA—kidney cancer	2.55e-06	8.62e-05	CbGpPWpGaD
Propafenone—ADRB1—Signaling Pathways—TP53—kidney cancer	2.47e-06	8.34e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTGS2—kidney cancer	2.43e-06	8.21e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTGS2—kidney cancer	2.41e-06	8.14e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PTEN—kidney cancer	2.25e-06	7.6e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PTEN—kidney cancer	2.12e-06	7.16e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PTEN—kidney cancer	2.1e-06	7.1e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTGS2—kidney cancer	2.06e-06	6.95e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—POMC—kidney cancer	1.99e-06	6.73e-05	CbGpPWpGaD
Propafenone—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.82e-06	6.15e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PTEN—kidney cancer	1.8e-06	6.06e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTGS2—kidney cancer	1.59e-06	5.37e-05	CbGpPWpGaD
Propafenone—ABCB1—Metabolism—PIK3CA—kidney cancer	1.59e-06	5.36e-05	CbGpPWpGaD
Propafenone—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.5e-06	5.05e-05	CbGpPWpGaD
Propafenone—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.48e-06	5.01e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PTEN—kidney cancer	1.39e-06	4.68e-05	CbGpPWpGaD
Propafenone—CYP1A2—Metabolism—PIK3CA—kidney cancer	1.27e-06	4.28e-05	CbGpPWpGaD
Propafenone—CYP3A4—Metabolism—PIK3CA—kidney cancer	9.78e-07	3.3e-05	CbGpPWpGaD
